Nuvalent Promotes Henry Pelish To Chief Scientific Officer

(RTTNews) - Biopharmaceutical company Nuvalent, Inc. (NUVL) announced Thursday that Henry Pelish has been promoted to Chief Scientific Officer. In this role, Pelish will continue to oversee discovery and early-stage development activities. He currently serves as Senior Vice Presi https://www.nasdaq.com/articles/nuvalent-promotes-henry-pelish-chief-scientific-officer